Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Menarini Silicon Biosystems announces new study results on use of CELLSEARCH® liquid biopsy for earlier detection of relapse and to help inform decisions on patient management in stage III Melanoma 2023-10-03 20:00
MedAlliance Acquired by Cordis for up to USD 1.135 Billion 2023-10-02 20:27
ZEISS and Boehringer Ingelheim join forces to develop early detection of eye diseases and prevent vision loss 2023-10-02 20:00
SIBIONICS to Make Debut at the 59th Annual Meeting of the European Association for the Study of Diabetes (EASD) 2023-10-02 16:24
MedAlliance Acquired by Cordis for USD 1.135 Billion 2023-10-02 11:44
WuXi Biologics Congratulates Amicus Therapeutics on U.S. FDA Approval for New Treatment for Pompe Disease 2023-10-02 08:30
Akeso and RemeGen Collaborate on Clinical Study Exploring the Potential of PD-1/CTLA-4 Bispecific Antibody with HER-2 ADC Combination Therapy in Gastric Cancer 2023-09-29 20:00
Bionomics Announces Positive Topline Results from the Phase 2b ATTUNE Clinical Trial of BNC210 in Patients with Post-Traumatic Stress Disorder (PTSD) 2023-09-29 12:13
Ascletis Announces Positive Interim Data from the Phase IIb Expansion Cohort of ASC22 (Envafolimab) for Chronic Hepatitis B Functional Cure 2023-09-29 08:10
Origin Agritech Limited Partners with Strategic Investor Relations, LLC to Support its Corporate Communications and Investor Relations Efforts 2023-09-28 23:34
SGC and HitGen Announce Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery 2023-09-28 21:30
ProfoundBio Announces Upcoming Scientific Presentations at SITC 2023 2023-09-28 20:00
Mabwell Announces First Patient Dosed in Phase Ib/II Trial of its Novel Nectin-4 Targeting ADC in Combination with PD-1 Inhibitor 2023-09-28 20:00
IASO Bio Presents Updated Long-Term Follow-Up Data for BCMA CAR-T FUCASO® (Equecabtagene Autoleucel) at IMS 2023 2023-09-28 18:09
BIOHK2023 LEAVES A MARK ON BIOTECH COMMUNITY: MUST-KNOW HIGHLIGHTS 2023-09-28 10:00
BioCity Signs Collaboration Agreement with AstraZeneca on BC3402, a monoclonal antibody targeting anti-TIM-3, in Combination with IMFINZI (durvalumab) for the Treatment of Advanced Hepatocellular Carcinoma in China 2023-09-28 09:46
Antengene To Present Results From Five Studies at 2023 SITC Annual Meeting 2023-09-28 08:30
Everest Medicines Announces Approval of XERAVA® in Taiwan for the Treatment of Complicated Intra-Abdominal Infections in Adult Patients 2023-09-28 07:38
Lunit to Reveal 6 Abstracts at the SITC 2023 Annual Meeting 2023-09-27 22:03
OBiO has launched its state-of-the-art GMP production facility Intelli-M to expedite innovative and advanced therapies to patients who are in need. 2023-09-27 21:00
1 78 79 80 81 82 452